вторник, 14 марта 2017 г.

Cytori Therapeutics Inc (CYTX) Stock Rating Upgraded by Zacks Investment Research

Cytori Therapeutics Inc (CYTX) Stock Rating Upgraded by Zacks Investment Research


According to Zacks, "Cytori Therapeutics, Inc. is discovering and developing proprietary cell-based therapeutics utilizing adult stem and regenerative cells derived from adipose tissue, also known as fat. The Company's preclinical investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders, and new approaches for aesthetic and reconstructive surgery.



from Biotech News